✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Vista Pharmaceuticals Ltd.

VISTAPH

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹61 Cr.
P/E
0.00

Vista Pharmaceuticals Ltd.

  • Vista Pharma
  • Bacil Pharma
  • Lasa Supergenerics

FAQs on Vista Pharmaceuticals Ltd. Shareprice

Vista Pharma has given lower returns compared to its competitors.
Vista Pharma has grown at ~-18.64% over the last 8yrs while peers have grown at a median rate of 12.17%

There is insufficient historical data to gauge this.
Latest PE of Vista Pharma is 0

View FAQ's On Business

Growth Table

  • Vista Pharmaceuticals Ltd.
  • Bacil Pharma
  • Lasa Supergenerics

Balance Sheet

  • Vista Pharmaceuticals Ltd.
  • Bacil Pharma
  • Lasa Supergenerics

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Vista Pharmaceuticals Ltd.
  • Bacil Pharma
  • Lasa Supergenerics

Cash Flow

  • Vista Pharmaceuticals Ltd.
  • Bacil Pharma
  • Lasa Supergenerics

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Vista Pharmaceuticals Ltd.
  • Bacil Pharma
  • Lasa Supergenerics

Quarterly Results

  • Vista Pharmaceuticals Ltd.
  • Bacil Pharma
  • Lasa Supergenerics

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Vista Pharmaceuticals Ltd. Financials

Balance sheet of Vista Pharma is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Vista Pharma is decreasing.
Latest net debt of Vista Pharma is ₹6.67 Crs as of Mar-25.
This is less than Mar-24 when it was ₹7.8 Crs.

The profit is oscillating.
The profit of Vista Pharma is -₹5.08 Crs for TTM, -₹4.51 Crs for Mar 2024 and -₹5.66 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Vista Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Capital Work in Progress, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech